These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28035400)

  • 1. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
    Zou YF; Xie CW; Yang SX; Xiong JP
    Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.
    Kwan HT; Chan DW; Cai PC; Mak CS; Yung MM; Leung TH; Wong OG; Cheung AN; Ngan HY
    PLoS One; 2013; 8(1):e53597. PubMed ID: 23301094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
    Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
    Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
    Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.
    Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E
    Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
    Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
    Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
    Dai YL; Huang SL; Leng Y
    Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
    Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
    Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
    Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
    Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of metformin response by breast cancer associated gene 2.
    Buac D; Kona FR; Seth AK; Dou QP
    Neoplasia; 2013 Dec; 15(12):1379-90. PubMed ID: 24403860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the AMP-activated protein kinase reduces inflammatory nociception.
    Russe OQ; Möser CV; Kynast KL; King TS; Stephan H; Geisslinger G; Niederberger E
    J Pain; 2013 Nov; 14(11):1330-40. PubMed ID: 23916727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-204-5p promotes the adipogenic differentiation of human adipose-derived mesenchymal stem cells by modulating DVL3 expression and suppressing Wnt/β-catenin signaling.
    He H; Chen K; Wang F; Zhao L; Wan X; Wang L; Mo Z
    Int J Mol Med; 2015 Jun; 35(6):1587-95. PubMed ID: 25847080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
    Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
    PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/β-catenin pathway in 3T3-L1 adipocytes.
    Lee H; Kang R; Bae S; Yoon Y
    Int J Mol Med; 2011 Jul; 28(1):65-71. PubMed ID: 21491080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
    Faggi L; Giustina A; Tulipano G
    Mol Cell Endocrinol; 2018 Jul; 470():60-74. PubMed ID: 28962892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro.
    Bizjak M; Malavašič P; Dolinar K; Pohar J; Pirkmajer S; Pavlin M
    Sci Rep; 2017 May; 7(1):1761. PubMed ID: 28496098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.